Related Experiment Videos
Campylobacter jejuni peritonitis complicating continuous ambulatory peritoneal dialysis
Journal of Clinical Microbiology
|October 1, 1982
Summary
Campylobacter jejuni peritonitis occurred in a patient undergoing continuous ambulatory peritoneal dialysis. Treatment with oral erythromycin and intraperitoneal gentamicin successfully resolved the infection.
Area of Science:
- Infectious Diseases
- Nephrology
- Gastroenterology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a treatment for end-stage renal disease.
- Peritonitis is a known complication of CAPD, often caused by bacterial infections.
- Campylobacter jejuni is a common cause of bacterial gastroenteritis.
Observation:
- A patient undergoing CAPD developed enteritis caused by Campylobacter jejuni.
- The patient subsequently developed peritonitis, a serious complication.
- This indicates a potential pathway for C. jejuni to cause peritonitis in CAPD patients.
Findings:
- The peritonitis was confirmed to be caused by Campylobacter jejuni.
- Treatment involved oral erythromycin and intraperitoneal gentamicin.
- Successful resolution of the peritonitis was achieved with this therapeutic regimen.
Implications:
- This case highlights the risk of Campylobacter jejuni peritonitis in CAPD patients.
- Early diagnosis and appropriate antibiotic therapy are crucial for managing this complication.
- The combination of oral and intraperitoneal antibiotics may be effective in treating C. jejuni peritonitis in this population.